Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S0140-6736(24)00481-1 | DOI Listing |
Antimicrob Agents Chemother
October 2024
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
The therapeutic challenges of orthopedic device-related infections and emerging antimicrobial resistance have attracted attention to drug delivery technologies. This study evaluates the preclinical efficacy of local single- and dual-antibiotic therapy against implant-associated osteomyelitis (IAO) using a drug-eluting depot technology, CarboCell, that provides sustained release of high-dose antibiotics and allows for strategic placement in relation to infectious lesions. Clindamycin and gentamicin were formulated in CarboCell compositions.
View Article and Find Full Text PDFJ Orthop Traumatol
July 2024
Department of Orthopaedic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Purpose: The aim of this study was to quantify the prophylactic effect of high-dose gentamicin and clindamycin antibiotic-loaded bone cement (ALBC) during revision total hip (rTHA) or knee (rTKA) arthroplasty for aseptic reasons. The hypothesis was that the raw surgical site infection (SSI) rate is lower when this particular cement is used in comparison with cement loaded with standard-dose gentamicin during rTHA or rTKA for aseptic reasons.
Methods: This retrospective study included 290 consecutive patients undergoing aseptic rTHA or rTKA.
BMC Infect Dis
June 2024
Department of Internal Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Lancet
May 2024
Oxford Trauma and Emergency Care, Kadoorie Centre, University of Oxford, Oxford OX3 9DU, UK. Electronic address:
Lancet
May 2024
Department of Orthopedics, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!